Patient sex
|
40.7% male (n = 183)
|
28.8% male (n = 115)
|
0.0001*
|
59.3% female (n = 267)
|
71.2% female (n = 284)
|
Patient age (y), (SD)
|
43.15 (SD 13.659)
|
39.71 (SD 13.637)
|
0.0001*
|
Radiculopathy present
|
11.2% (n = 49)
|
17.3% (n = 69)
|
0.014*
|
Pain medication use
|
27% (n = 121)
|
35% (n = 140)
|
0.046*
|
Chronicity <4 weeks (acute)
|
44.9% (n = 197)
|
44.1% (n = 174)
|
0.02*
|
Chronicity 4–8 weeks (subacute)
|
8.9% (n = 39)
|
12.9% (n = 51)
|
Chronicity 8–12 weeks (subacute)
|
11.4% (n = 50)
|
6.1% (n = 24)
|
Chronicity >12 weeks (chronic)
|
34.9% (n = 153)
|
37.0% (n = 146)
|
Baseline NRS (SD)
|
5.951 (SD 2.211)
|
5.561 (SD 2.256)
|
0.012*
|
BQ1 (pain)
|
5.680 (SD 2.262)
|
5.651 (SD 2.306)
|
0.853
|
BQ2 (disability in ADL)
|
4.185 (SD 2.823)
|
3.999 (SD 2.764)
|
0.337
|
BQ3 (disability in social activities)
|
3.614 (SD 3.120)
|
3.433 (SD 3.079)
|
0.400
|
BQ4 (anxiety)
|
5.382 (SD 2.883)
|
5.344 (SD 2.827)
|
0.851
|
BQ5 (depression)
|
3.441 (SD 3.099)
|
3.376 (SD 3.066)
|
0.762
|
BQ6 (work realted fear avoidance)
|
4.442 (SD 2.936)
|
4.577 (SD 3.064)
|
0.515
|
BQ7 (pain locus of control})
|
5.035 (SD 2.864)
|
4.916 (SD 2.846)
|
0.548
|
Baseline BQ total (SD)
|
31.761 (SD 15.124)
|
31.319 (SD 15.396)
|
0.676
|